Real Estate Not Included in List Price.  Business Price $19.3M, CRE price $18M. Total Combined $37.3M. Targeting Sale of Both.

This highly profitable, one-of-a-kind integrative and functional medicine practice is one of the largest and most established platforms of its kind in the United States. Founder-led and operating for more than 40 years, the practice has treated more than 100,000 patients who travel from across the country and around the world for individualized, whole-person, root-cause care. Operating two complementary clinics under one roof from a single, fully built-out campus, the practice's services span integrative oncology and cancer prevention, functional and preventive medicine, women's health, hormone optimization, autoimmune and chronic disease management, human optimization, longevity, and medical aesthetics — all supported by comprehensive in-house diagnostics. The business operates with a deep, multidisciplinary team of physicians and licensed practitioners, along with full front-office and back-office support, and there is no indication of employee departures post-close.



The revenue model is exceptionally attractive: predominantly cash-pay with roughly 80% gross margins and no dependence on insurance reimbursement. Revenue is well diversified across integrative cancer services (~37%), a proprietary branded line of supplement and wellness products (~28%) sold through an in-facility retail store and a growing e-commerce channel, general medical services (~20%), and wellness services (~11%). The product line gives the company the rare profile of a medical practice, consumer products business, and e-commerce platform in one, generating recurring revenue and long-term patient engagement. With an enormous active patient base built over three decades, there is no customer concentration risk, and the nationally recognized brand continues to draw new patients without reliance on any single referral source.



From an investment perspective, this is a true platform acquisition. Integrative and functional medicine is one of the fastest-growing segments of healthcare, and the space remains highly fragmented. A private equity firm or strategic buyer could acquire this company as the gold standard in the industry and pursue multiple built-in growth levers: recruiting additional physicians into existing unused capacity, expanding the branded product line nationally, launching digital health and telehealth offerings, and adding locations in new geographies — driving both top-line and bottom-line growth as well as EBITDA multiple expansion for a future exit. The founder is open to a 2–3 year employment agreement to ensure a smooth transition, and the owner-occupied real estate housing the practice is also available for purchase, offering the buyer full control of the campus.

In 2025 the company generated $18.6M in revenue at a 79.9% gross margin, producing $3.0M in SDE and $2.6M in Adjusted EBITDA. On a three-year weighted-average basis, the business has generated approximately $19.5M in revenue, $4.1M in SDE, and $3.7M in Adjusted EBITDA.

For more information, please contact the M&A Advisor brokering the sale, Chris Beckman, by emailing him at cbeckman@tworld.com, or by calling 714-824-4492. All buyers are required to sign an NDA and complete a Buyer Profile before any confidential information is released.